Editorial
Wind of change in surgical treatment of thymic tumors
Abstract
Thymic tumors are a rare entity with a peculiar behavior ranging from indolent neoplasms to aggressive cancers (1). Complete surgical resection is advocated as the gold standard when feasible (2); chemotherapy and radiotherapy can be administered as an induction at advanced stages unsuitable for complete resection (3) or as adjuvant treatment in case of advanced pathological stages, aggressive histologies (3,4) or R+ resection.